INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $158,000 | +9.0% | 7,341 | 0.0% | 0.01% | -68.6% |
| Q2 2022 | $145,000 | -16.2% | 7,341 | 0.0% | 0.04% | +6.1% |
| Q1 2022 | $173,000 | -13.5% | 7,341 | 0.0% | 0.03% | -2.9% |
| Q4 2021 | $200,000 | -7.0% | 7,341 | -6.0% | 0.03% | -10.5% |
| Q3 2021 | $215,000 | -3.2% | 7,813 | 0.0% | 0.04% | +8.6% |
| Q2 2021 | $222,000 | -16.5% | 7,813 | 0.0% | 0.04% | -22.2% |
| Q1 2021 | $266,000 | +2.3% | 7,813 | 0.0% | 0.04% | +2.3% |
| Q4 2020 | $260,000 | +3.6% | 7,813 | 0.0% | 0.04% | -6.4% |
| Q3 2020 | $251,000 | +16.7% | 7,813 | 0.0% | 0.05% | +20.5% |
| Q2 2020 | $215,000 | +156.0% | 7,813 | +48.3% | 0.04% | +116.7% |
| Q1 2020 | $84,000 | -33.3% | 5,270 | 0.0% | 0.02% | -21.7% |
| Q4 2019 | $126,000 | +35.5% | 5,270 | 0.0% | 0.02% | +27.8% |
| Q3 2019 | $93,000 | -31.1% | 5,270 | 0.0% | 0.02% | -25.0% |
| Q2 2019 | $135,000 | – | 5,270 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 961,797 | $32,018,000 | 11.45% |
| Palo Alto Investors LP | 6,105,980 | $203,268,000 | 10.66% |
| Sycale Advisors (NY) LLC | 303,902 | $10,117,000 | 7.21% |
| Burrage Capital Management LLC | 154,562 | $5,145,000 | 3.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 175,000 | $5,826,000 | 3.38% |
| First Light Asset Management, LLC | 1,071,219 | $35,661,000 | 2.64% |
| Altium Capital Management LP | 148,743 | $4,952,000 | 1.85% |
| Endurant Capital Management LP | 124,323 | $4,139,000 | 1.49% |
| Bellevue Group AG | 1,617,000 | $53,830,000 | 0.62% |
| Novo Holdings A/S | 430,107 | $14,318,000 | 0.61% |